The integration of clinical information and drug discovery is critical to providing customized solutions for patient stratification and treatment selection. To help improve clinical trial success rates, we offer a wide range of biomarker solutions. Clinical trial customers have access to our extensive line of proprietary tests for hematological and solid-tumor cancers, as well as off-the-shelf assays. Pharma Solutions also offers an extensive portfolio of genotyping services, with access to more than 250 validated genotyping assays including Phase I and Phase II drug-metabolizing enzymes, transporters, and receptors, and more than 30 validated gene expression assays.
When it comes to clinical trials, time is of the essence. We work to provide time-sensitive trial test development, rapid proof-of-concept studies, and dependable results from early-phase initiatives.